Literature DB >> 7696334

Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid.

I Borghini1, F Barja, D Pometta, R W James.   

Abstract

The aim of the present study was to define lipoprotein complexes within cerebrospinal fluid (CSF) in terms of their apolipoprotein composition, using fractionation procedures considered optimal for maintaining lipoprotein structural integrity. Five apolipoproteins were identified, namely apolipoproteins A-I, A-IV, D, E and J. These were differentially distributed amongst lipoprotein particles of which three major subpopulations were identified. CSF-LpAI (20.1 +/- 3.8 nm) was enriched in apolipoprotein A-I and contained the major proportion (> 50%) of apolipoproteins D, E and J. CSF-LpE, of similar size to CSF-LpAI (20.2 +/- 3.1 nm), was composed principally of apolipoprotein E, with minor quantities of apolipoproteins A-I, A-IV, D and J. Elimination of these particles from cerebrospinal fluid by immunoabsorption revealed a third subpopulation of significantly greater diameter (32.0 +/- 6.8 nm). The majority (62%) of apolipoprotein A-IV was also present in this fraction. The study demonstrates the structural and size heterogeneity of lipoproteins in cerebrospinal fluid. This may reflect the lipid transport processes within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7696334     DOI: 10.1016/0005-2760(94)00232-n

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  39 in total

1.  Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

Authors:  M D Neely; L L Swift; T J Montine
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

2.  Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Authors:  C N Bassett; M D Neely; K R Sidell; W R Markesbery; L L Swift; T J Montine
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

3.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

4.  Protein arginylation in rat brain cytosol: a proteomic analysis.

Authors:  María Belén Decca; Christophe Bosc; Sylvie Luche; Sabine Brugière; Didier Job; Thierry Rabilloud; Jerôme Garin; Marta Elena Hallak
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

5.  Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.

Authors:  Hideru Obinata; Andrew Kuo; Yukata Wada; Steven Swendeman; Catherine H Liu; Victoria A Blaho; Rieko Nagumo; Kenichi Satoh; Takashi Izumi; Timothy Hla
Journal:  J Lipid Res       Date:  2019-08-28       Impact factor: 5.922

6.  Increased expression of ApoA1 after neuronal injury may be beneficial for healing.

Authors:  Mohor B Sengupta; Suparna Saha; Pradeep K Mohanty; Kiran K Mukhopadhyay; Debashis Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2016-10-13       Impact factor: 3.396

7.  Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.

Authors:  Enkhzol Malchinkhuu; Koichi Sato; Takeshi Muraki; Koichi Ishikawa; Atsushi Kuwabara; Fumikazu Okajima
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 8.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

9.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

10.  Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.

Authors:  Ronald B DeMattos; Mark A O'dell; Maia Parsadanian; Jennie W Taylor; Judith A K Harmony; Kelly R Bales; Steven M Paul; Bruce J Aronow; David M Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.